Meet the Team
The CHRI team brings a multidisciplinary approach to understanding the health effects of medicinal cannabis use. Our team provides world-renowned expertise in behavioral pharmacology, public health, toxicology, analytical chemistry, computer science, regulatory science, data integration and analysis, and the use of applied technologies in health research.
Study Team
Steering Committee
Bernal Jiménez Gutiérrez
Johns Hopkins University
Ahmed Hassoon, MD, MPH
Johns Hopkins University
Robert W. Klingensmith III
Parkway Digital
Clarissa Madar, BA
Johns Hopkins University
Nazia Qureshi
Johns Hopkins University
External Advisory Board
Marcel Bonn-Miller, PhD
Chief Scientific Officer
Charlotte’s Web
Geisel School of Medicine at Dartmouth
Center for Technology and Behavioral Health
Mahmoud ElSohly, PhD
Founder/Board President
Realm of Caring Foundation
Gillian Schauer, PhD, MPH
Roswell Park Comprehensive Cancer Center
Jeff Scott (BA; U.S. Army, Ret.)
Joel Stanley
CHRI aims to inform clinical decision-making, product development and public policy related to the therapeutic use of cannabinoids.